ExactCure and personalized modeling of drugs: How to translate science into a company
ExactCure is a newborn company that aims at modeling the precise action of a drug on a precise patient.
Taking the right drug for the right patient at the right time is a critical issue in modern health. There are more people dying of inappropriate medication than car accidents and suicides together! The cost has been estimated to 10 billion euros per year, only for the French Social Security.
Why is it so complex? We are all different; we differently respond to drugs, but we usually have one same posology for everyone. The principle of personalized medicine is to find the exact treatment for each patient. Now ExactCure opens the way to what we call personalized modeling.
In order to achieve this ambitious goal, ExactCure leverages an expertise in pharmacology, dynamic systems and control theory. This talk from Frédéric Dayan, ExactCure’s founder, will be focused on the transition between a scientific project and a real company.